Abstract
Extracorporeal membrane oxygenation (ECMO) is a modification of classic cardiopulmonary bypass (CPB) intended for the long term support of patients with life threatening cardiac and/or respiratory failure. In terms both of the numbers of patients treated and the success of those treatments, its most important application has been to neonatal patients with acute respiratory failure. Since the first successful neonatal ECMO case was reported in 1976 by Bartlett and colleagues [1], more than 13,000 patients have been supported with this technology, of whom more than 10,000 have been newborns (Table 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW. (1976) Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans. Am. Soc. Artif. Intern. Organs, 22:80–93.
Shanley CJ, Hirschl RB, Schumacher RE, et al. (1994) Extracorporeal life support for neonatal respiratory failure. A 20-year experience. Annals of Surgery, 220:269–80: discussion 281–2.
Zwischenberger JB, Nguyen TT, Upp JR, Jr., et al. (1994) Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg, 107:838–48: discussion 848–9.
Glass P, Wagner AE, Papero PH, et al. (1995) Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. Journal of Pediatrics, 127:447–457.
Rais-Bahrami K, Coffman C, Wagner A, Bulas D, Glass P, Short B. (1995) Outcome of ECMO vs. near miss ECMO patients at five years of age. 11th Annual CNMC Symmposium on ECMO and Advanced Therapies for Respiratory Failure. Keystone, CO, March 1995.
Anonymous (1993) Report of the Workshop on Diffusion of ECMO Technology. Extracorporeal Membrane Oxygenation. NIH Publication No. 93–3399, Rockville, MD.
Guyer B, Strobino DM, Ventura SJ, Singh GK. (1995) Annual summary of vital statistics-1994. Pediatrics, 96:1029–1039.(Abstract)
Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB. (1985) Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatrics, 76:479–487.
O’Rourke PP, Crone RK, Vacanti JP, et al. (1989) Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics, 84:957–963.
Schumacher RE. (1993) Extracorporeal membrane oxygenation. Will this therapy continue to be as efficacious in the future?. [Review]. Pediatr Clin North Am, 40:1005–1022.
Wung J, James LS, Kilchevsky E, James E. (1985) Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics, 76:488–494.
Long W, Zucker J, Kraybill E. (1995) Symposium on synthetic surfactant II: perspective and commentary. J Pediatr, 126:Sl-S4.(Abstract)
Bui KC, Walther FJ, David Cu R, Garg M, Warburton D. (1992) Phospholipid and surfactant protein A concentrations in tracheal aspirates from infants requiring extracorporeal membrane oxygenation. Journal of Pediatrics, 121:271–274.
Lotze A, Stroud CY, Soldin SJ. (1995) Serial lecithin/sphingomyelin ratios and surfactant/ albumin ratios in tracheal aspirates from term infants with respiratory failure receiving extracorporeal membrane oxygenation. Clinical Chemistry, 41:1182–1188.
Findlay RD, Taeusch HW, Walther FJ. (1996) Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics, 97:48–52.(Abstract)
Lotze A, Knight GR, Martin GR, et al. (1993) Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr, 122:261–268.
Lotze A, Knight GR, Anderson KD, et al. (1994) Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg, 29:407–412.
Lotze A, The Survanta in Term Infants Study Group. (1996) Survanta pre-ECMO trial: multicenter evaluation of Survanta in treatment of term infants with severe respiratory failure. 12th Annual CNMC Symmposium on ECMO and Advanced Therapies for Respiratory Failure. Keystone, CO, February 1996.
Bell RE, Kuehl TJ, Coalson JJ, et al. (1984) High frequency ventilation compared to conventional positive-pressure ventilation in the treatment of hyaline membrane disease in primates. Crit. Care Med. 12:764–767.
The HIFI Study Group. (1989) High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. New England Journal of Medicine, 320:88–93.
HO Study Group.(1993) Randomized study of high-frequency oscillatory ventilation in infants with severe respiratory distress syndrome. Journal of Pediatrics, 122:609–619.
Ogawa Y, Miyasaka K, Kawano T, et al. (1993) A multicenter randomized trial of high frequency oscillatory ventilation as compared with conventional mechanical ventilation in preterm infants with respiratory failure. Early Human Development, 32:1–10.
Clark RH, Gerstmann DR, Null DM, Jr, demos RA. (1992) Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics, 89, 5–12.
Imai Y, Kawano T, Miyasaka K, Takata M, Imai T, Okuyama K. (1994) Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. American Journal of Respiratory & Critical Care Medicine, 150:1550–1554.
Cornish JD, Gerstmann DR, Clark RH, Carter JM, Null DM, Jr, demos RA. (1987) Extracorporeal membrane oxygenation and high-frequency oscillatory ventilation: potential therapeutic relationships. Crit. Care Med. 15:831–834.
Carlo WA, Beoglos A, Chatburn RL, Walsh MC, Martin RJ. (1989) High-frequency jet ventilation in neonatal pulmonary hypertension. Am. J. Dis. Child, 143:233–238.
Kohelet D, Perlman M, Kirpalani H, Hanna G, Koren G. (1988) High-frequency oscillation in the rescue of infants with persistent pulmonary hypertension. Crit. Care Med. 16:510–516.
Tamura M, Tsuchida Y, Kawano T, et al. (1988) Piston-pump-type high frequency oscillatory ventilation for neonates with congenital diaphragmatic hernia: a new protocol. J Pediatr. Surg. 23:478–482.
Carter JM, Gerstmann DR, Clark RH, et al. (1990) High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of acute neonatal respiratory failure. Pediatrics, 85:159–164.
Delemos R, Yoder B, Murnin D, Kinsella J, Clark R, Null D. (1992) The use of high-frequency oscillatory ventilation (HFOV) and extracorporeal membrane oxygenation (ECMO) in the management of the term/near term infant with respiratory failure. Early Human Development, 29:299–303.
Varnholt V, Lasch P, Suske G, Kachel W, Brands W. (1992) High frequency oscillatory ventilation and extracorporeal membrane oxygenation in severe persistent pulmonary hypertension of the newborn. Eur. J Pediatr, 151:769–774.
Miguet D, Cagnin S, Claris O, Lapillonne A, Salle BL. (1994) [Persistence of fetal circulation and high frequency oscillation]. [French]. Cahiers d Anesthesiologie, 42:319–324.
Miguet D, Claris O, Lapillonne A, Bakr A, Chappuis JP, Salle BL. (1994) Preoperative stabilization using high-frequency oscillatory ventilation in the management of congenital diaphragmatic hernia. Critical Care Medicine, 22: S77–82.
Clark RH, Yoder BA, Sell MS. (1994) Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr, 124:447–454.
Bond DM, Froese AB. (1993) Volume recruitment maneuvers are less deleterious than persistent low lung volumes in the atelectasis-prone rabbit lung during high-frequency oscillation. Crit. Care Med. 21:402–412.
Arnold JH, Hanson JH, Toro-Figuero LO, Gutierrez J, Berens RJ, Anglin DL. (1994) Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Critical Care Medicine, 22:1530–1539.
Kinsella JP, Mueston J A, Rosenberg AA, et al. (1992) Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. American Journal of Physiology, 263:H875-H880.
Roberts JD, Jr., Chen TY, Kawai N, et al. (1993) Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circulation Research, 72:246–254.
Roberts JD, Polaner DM, Lang P, Zapol WM. (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet, 340:818–819.
Kinsella JP, Neish SR, Shaffer E, Abman SH. (1992) Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet, 340:819–820.
Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. (1993) Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics, 92, 606–609.
Kinsella JP, Toews WH, Henry D, Abman SH. (1993) Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. Journal of Pediatrics, 122:803–806.
Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. (1993) Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide [see comments]. Journal of Pediatrics, 123:103–108.
Kinsella JP, Abman SH. (1993) Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics, 91:997–998.
Abman SH. (1994) Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension. [Review]. Current Opinion in Pediatrics, 6:239–247.
Roberts JD, Jr. (1993) Inhaled nitric oxide for treatment of pulmonary artery hypertension in the newborn and infant. [Review]. Critical Care Medicine, 21:S374–6.
Roberts JD, Jr., Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. (1993) Inhaled nitric oxide in congenital heart disease. Circulation, 87:447–453.
Karamanoukian HL, Glick PL, Zayek M, et al. (1994) Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics, 94:715–718.
Karamanoukian HL, Glick PL, Wilcox DT, Rossman JE, Holm BA, Morin FC. (1995) Pathophysiology of congenital diaphragmatic hernia. VIII: Inhaled nitric oxide requires exogenous surfactant therapy in the lamb model of congenital diaphragmatic hernia. Journal of Pediatric Surgery, 30:1–4.
Rossaint R, Gerlach H, Falke KJ. (1994) Inhalation of nitric oxide-a new approach in severe ARDS. [Review]. European Journal of Anaesthesiology, 11:43–51.
Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. (1994) Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr, 124:302–308.
Peliowski A, Finer NN, Etches PC, Tierney AJ, Ryan CA. (1995) Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. Journal of Pediatrics, 126:450–453.
Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ. (1993) Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 19:443–449.
Gerlach H, Rossaint R, Pappert D, Falke KJ. (1993) Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. European Journal of Clinical Investigation, 23:499–502.
Stark AR, Davidson D. (1995) Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: implications and strategy for future “high-tech” neonatal clinical trials. [Review]. Pediatrics, 96:1147–1151.
Abman SH, Kinsella JP. (1995) Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: the physiology matters: [comment]. [Review]. Pediatrics, 96:1153–1155.
Kornhauser MS, Cullen JA, Baumgart S, Mee LJ, Gross GW, Spitzer AR. (1994) Risk factors for bronchopulmonary dysplasia after extracorporeal membrane oxygenation. Archives of Pediatrics & Adolescent Medicine, 148:820–825.
Leach CL, Fuhrman BP, Morin FC, 3rd, Rath MG. (1993) Perfluorocarbon-associated gas exchange (partial liquid ventilation) in respiratory distress syndrome: a prospective, randomized, controlled study. Critical Care Medicine, 21:1270–1278.
Fuhrman BP. (1990) Perfluorocarbon liquid ventilation: the first human trial. Journal of Pediatrics, 117:73–74.
Gross GW, Greenspan JS, Fox WW, Rubenstein SD, Wolfson MR, Shaffe H. (1995) Use of liquid ventilation with perflubron during extracorporeal membrane oxygenation: chest radiographic appearances. Radiology, 194:717–720.
Hirschl RB, Tooley R, Parent AC, Johnson K, Bartlett RH. (1995) Improvement of gas exchange, pulmonary function, and lung injury with partial liquid ventilation. A study model in a setting of severe respiratory failure. Chest, 108:500–508.
Tutuncu AS, Akpir K, Mulder P, Erdmann W, Lachmann B. (1993) Intratracheal perfluorocarbon administration as an aid in the ventilatory management of respiratory distress syndrome. Anesthesiology, 79:1083–1093.
Tutuncu AS, Faithfull NS, Lachmann B. (1993) Comparison of ventilatory support with intratracheal perfluorocarbon administration and conventional mechanical ventilation in animals with acute respiratory failure. American Review of Respiratory Disease, 148:785–792.
Lowe CA, Shaffer TH. (1986) Pulmonary vascular resistance in the fluorocarbon-filled lung. J Appl Physiol, 60:154–159.
Lane T, Smith D, Wancewicz E, Funk R. (1992) Inhibition of endotoxin-mediated activation of endothelial cells by a perfluorocarbon emulsion. Biomater. Artif Cells Immobilization. Biotechnol. 20:1051–1057.
Hirschl RB, Parent A, Tooley R, Shaffer T, Wolfson M, Bartlett RH. (1994) Lung management with perfluorocarbon liquid ventilation improves pulmonary function and gas exchange during extracorporeal membrane oxygenation (ECMO). Artificial Cells, Blood Substitutes, & Immobilization Biotechnology, 22:1389–1396.
Leach CL, Holm B, Morin FC, 3rd, et al. (1995) Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant. Journal of Pediatrics, 126:412–420.
Hirschl RB, Pranikoff T, Gauger P, et al. (1995) Liquid ventilation in adults, children, and full-term neonates. Lancet, 346, 1201–1202.
Kinsella JP, Abman SH. (1995) Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. [Review]. Journal of Pediatrics, 126:853–864.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cornish, J.D. (1996). The Changing Pattern of Neonatal ECMO: Do we Really Need it?. In: Tibboel, D., van der Voort, E. (eds) Intensive Care in Childhood. Update in Intensive Care and Emergency Medicine, vol 25. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80227-0_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-80227-0_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80229-4
Online ISBN: 978-3-642-80227-0
eBook Packages: Springer Book Archive